683 Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

683 Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$166K	–	255
2020 Q4	$166K	Buy	+30,000	New	+$133K	0.01%	201
2018 Q2	–	Sell	-21,660	Closed	-$73K	–	163
2018 Q1	$73K	Sell	21,660 -102,897	-83%	-$651K	0.01%	132
2017 Q4	$859K	Sell	124,557 -124,743	-50%	-$865K	0.07%	107
2017 Q3	$1.6M	Sell	249,300 -41,609	-14%	-$267K	0.17%	82
2017 Q2	$1.79M	Buy	+290,909	New	+$2.13M	0.26%	70
2016 Q4	–	Sell	-23,384	Closed	-$2.71M	–	118
2016 Q3	$2.71M	Buy	23,384 +1,009	+5%	+$98.4K	0.29%	58
2016 Q2	$1.77M	Sell	22,375 -1,327	-6%	-$115K	0.28%	50
2016 Q1	$1.8M	Buy	23,702 +14,952	+171%	+$950K	0.32%	44
2015 Q4	$784K	Hold	8,750	–	–	0.11%	83
2015 Q3	$980K	Hold	8,750	–	–	0.14%	73
2015 Q2	$890K	Buy	+8,750	New	+$905K	0.18%	68

Other funds holding PLXP

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

683 Capital Management's PLXP Position: Q1 2021 in Review

683 Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2021, closing a stake of 30,000 shares — an estimated $166K sold.

683 Capital Management first reported a position in PLXP in Q2 2015 and held it in 11 quarters. The position peaked at $2.71M in Q3 2016. 37 funds tracked by Wall St. Rank hold PLXP as of Q1 2021.

683 Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
683 Capital Management sold 30,000 PLx Pharma Inc. Common Stock shares in Q1 2021, an estimated $166K.
683 Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q2 2015 and held it in 11 quarters.
683 Capital Management's PLx Pharma Inc. Common Stock position peaked at $2.71M in Q3 2016.
37 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2021.

Based on 683 Capital Management's 13F filing for Q1 2021, filed 17 May 2021.